1. Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin 
Jean–François Rossignol, Asem Elfert, Yehia El–Gohary, Emmet B. Keeffe 
Gastroenterology 
Volume 136, Issue 3, Pages (March 2009)
DOI: /j.gastro
Copyright © 2009 AGA Institute Terms and Conditions

2. Figure 1
Study design. NTZ, nitazoxanide 500 mg twice daily; Peg-IFN alfa-2a, peginterferon alfa-2a 180 μg/wk.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

3. Figure 2
Patient disposition flowchart. NTZ, nitazoxanide 500 mg twice daily; PegIFN, peginterferon alfa-2a 180 μg/wk; RBV, ribavirin 1000–1200 mg/day.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions